InsidersTradesSigma
Track the Jubilant Pharmova stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €139.3bn. The latest transaction was reported on 30 June 2026 (Pledge). Among the most active insiders: HSB Trustee Company Private Ltd and HS Trustee Company Pvt Ltd. Every trade is openly available.
Analysts rate Jubilant Pharmova Buy (bullish), based on 2 analysts. Average price target: ₹1,088.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Jubilant Pharmova es una empresa farmacéutica centrada en la fabricación de productos farmacéuticos y servicios de atención médica. Cotiza en la Bolsa de Bombay bajo el símbolo XBOM.